Development of stereotactic mass spectrometry for brain tumor surgery

Neurosurgery

Volumn 68, Issue 2, 2011, Pages 280-290

  Agar, Nathalie Y R ^a   Golby, Alexandra J ^a,b   Ligon, Keith L ^a   Norton, Isaiah ^a   Mohan, Vandana ^c   Wiseman, Justin M ^d   Tannenbaum, Allen ^c   Jolesz, Ferenc A ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Department of Radiology ^*  (United States)

^c GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^d PROSOLIA INC   (United States)

Author keywords

Brain neoplasms; Histopathology; Mass spectrometry; Neuronavigation; Neurosurgery; Stereotactic techniques

Indexed keywords

CONTRAST MEDIUM; LIPID;

ARTICLE; BRAIN SURGERY; BRAIN TISSUE; BRAIN TUMOR; CANCER GRADING; CANCER INFILTRATION; CANCER SURGERY; CASE STUDY; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME DELETION; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; FRONTAL LOBE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MOLECULAR IMAGING; MOLECULAR MECHANICS; MOLECULAR TISSUE CHARACTERIZATION; NEUROSURGERY; OLIGODENDROGLIOMA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STEREOTACTIC PROCEDURE; TANDEM MASS SPECTROMETRY; THREE DIMENSIONAL IMAGING; TISSUE CHARACTERIZATION; TUMOR CELL; TUMOR DIAGNOSIS; TUMOR RECURRENCE; TUMOR VOLUME; WORLD HEALTH ORGANIZATION;

BRAIN NEOPLASMS; HUMANS; MASS SPECTROMETRY; NEURONAVIGATION; NEUROSURGICAL PROCEDURES;

EID: 79951673443     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e3181ff9cbb     Document Type: Article

References (43)

1. Cha S. Update on brain tumor imaging. Curr Neurol Neurosci Rep. 2005;5(3):169-177. (Pubitemid 40873032)
2. Yip S, Iafrate AJ, Louis DN. Molecular diagnostic testing in malignant gliomas: a practical update on predictive markers. J Neuropathol Exp Neurol. 2008;67(1): 1-15.
3. Furnari FB, Fenton T, Bachoo RM, et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev. 2007;21(21):2683-2710. (Pubitemid 350070717)
4. Philippon JH, Clemenceau SH, Fauchon FH, Foncin JF. Supratentorial low-grade astrocytomas in adults. Neurosurgery. 1993;32(4):554-559. (Pubitemid 23099519)
5. Janny P, Cure H, Mohr M, et al. Low grade supratentorial astrocytomas: management and prognostic factors. Cancer. 1994;73(7):1937-1945. (Pubitemid 24101975)
6. Healy GB, Upton J, Black PM, Ferraro N. The role of surgery in rhabdomyosarcoma of the head and neck in children. Arch Otolaryngol Head Neck Surg. 1991;117(10):1185-1188.
7. Piepmeier J, Christopher S, Spencer D, et al. Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas. Neurosurgery. 1996;38(5):872-878.
8. Talos IF, Zou KH, Ohno-Machado L, et al. Supratentorial low-grade glioma resectability: statistical predictive analysis based on anatomic MR features and tumor characteristics. Radiology. 2006;239(2):506-513.
9. Moriarty TM, Kikinis R, Jolesz FA, Black PM, Alexander E III. Magnetic resonance imaging therapy. Intraoperative MR imaging. Neurosurg Clin N Am. 1996;7(2):323-331.
10. Jolesz FA, Talos IF, Schwartz RB, et al. Intraoperative magnetic resonance imaging and magnetic resonance imaging-guided therapy for brain tumors. Neuroimaging Clin N Am. 2002;12(4):665-683. (Pubitemid 36015498)
11. Schwartz RB, Hsu L, Wong TZ, et al. Intraoperative MR imaging guidance for intracranial neurosurgery: experience with the first 200 cases. Radiology. 1999;211(2):477-488. (Pubitemid 29206820)
12. Upadhyay UM, Golby AJ. Role of pre- and intraoperative imaging and neuronavigation in neurosurgery. Expert Rev Med Devices. 2008;5(1):65-73.
13. Black PM,Moriarty T, Alexander E III, et al. Development and implementation of intraoperative magnetic resonance imaging and its neurosurgical applications. Neurosurgery. 1997;41(4):831-842.
14. Stoeckli M, Chaurand P, Hallahan DE, Caprioli RM. Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues. Nat Med. 2001;7(4):493-496. (Pubitemid 32298555)
15. Chaurand P, Schwartz SA, Billheimer D, Xu BJ, Crecelius A, Caprioli RM. Integrating histology and imaging mass spectrometry. Anal Chem. 2004;76(4):1145-1155. (Pubitemid 38235565)
16. Chaurand P, Schwartz SA, Caprioli RM. Assessing protein patterns in disease using imaging mass spectrometry. J Proteome Res. 2004;3(2):245-252. (Pubitemid 38500991)
17. Schwartz SA, Weil RJ, Thompson RC, et al. Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry. Cancer Res. 2005;65(17):7674-7681. (Pubitemid 41297241)
18. Takats Z, Wiseman JM, Gologan B, Cooks RG. Mass spectrometry sampling under ambient conditions with desorption electrospray ionization. Science. 2004;306(5695):471-473. (Pubitemid 39372443)
19. Wiseman JM, Puolitaival SM, Takats Z, Cooks RG, Caprioli RM. Mass spectrometric profiling of intact biological tissue by using desorption electrospray ionization. Angew Chem Int Ed Engl. 2005;44(43):7094-7097. (Pubitemid 41587581)
20. Wiseman JM, Ifa DR, Song Q, Cooks RG. Tissue imaging at atmospheric pressure using desorption electrospray ionization (DESI) mass spectrometry. Angew Chem Int Ed Engl. 2006;45(43):7188-7192. (Pubitemid 44748295)
21. Wiseman JM. Development of Desorption Electrospray Ionization (DESI) Mass Spectrometry and Its Application to Direct Biological Tissue Analysis and Molecular Imaging. West Lafayette, IN: Purdue University; 2006.
22. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK.WHO Classification of Tumors of the Central Nervous System. 4th ed. Lyon, Switzerland: WHO Press; 2007.
23. Wiseman JM, Ifa DR, Venter A, Cooks RG. Ambient molecular imaging by desorption electrospray ionization mass spectrometry. Nat Protoc. 2008;3(3): 517-524. (Pubitemid 351372236)
24. Ifa DR, Manicke NE, Rusine AL, Cooks RG. Quantitative analysis of small molecules by desorption electrospray ionization mass spectrometry from polytetrafluoroethylene surfaces. Rapid Commun Mass Spectrom. 2008;22(4):503-510. (Pubitemid 351300584)
25. Manicke NE, Wiseman JM, Ifa DR, Cooks RG. Desorption electrospray ionization (DESI) mass spectrometry and tandem mass spectrometry (MS/MS) of phospholipids and sphingolipids: ionization, adduct formation, and fragmentation. J Am Soc Mass Spectrom. 2008;19(4):531-543.
26. Zhang X, Reid G. Multistage tandem mass spectrometry of anionic phosphatidylcholine lipid adducts reveals novel dissociation pathways Int J Mass Spectrom. 2006;252(3):242-255.
27. Sud M, Fahy E, Cotter D, et al. LMSD: LIPID MAPS structure database. Nucleic Acids Res. 2007;35(database issue):D527-D532. (Pubitemid 46056264)
28. Fahy E, Subramaniam S, Murphy RC, et al. Update of the LIPID MAPS comprehensive classification system for lipids. J Lipid Res. 2009;50(Suppl):S9-S14.
29. Murphy RC, Hankin JA, Barkley RM. Imaging of lipid species by MALDI mass spectrometry. J Lipid Res. 2009;50(Suppl):S-317-S-322.
30. Watson JT, Sparkman OD. Introduction to Mass Spectrometry: Instrumentation, Applications, and Strategies for Data Interpretation. 4th ed. Hoboken, NJ: John Wiley & Sons, Ltd; 2008.
31. Cooks RG, Ouyang Z, Takats Z, Wiseman JM. Detection technologies: ambient mass spectrometry. Science. 2006;311(5767):1566-1570.
32. Uematsu Y, Owai Y, Okita R, Tanaka Y, Itakura T. The usefulness and problem of intraoperative rapid diagnosis in surgical neuropathology. Brain Tumor Pathol. 2007;24(2):47-52. (Pubitemid 350165710)
33. Tilgner J, Herr M, Ostertag C, Volk B. Validation of intraoperative diagnoses using smear preparations from stereotactic brain biopsies: intraoperative versus final diagnosis: influence of clinical factors. Neurosurgery. 2005;56(2):257-265.
34. Nabavi A, Black PM, Gering DT, et al. Serial intraoperative magnetic resonance imaging of brain shift. Neurosurgery. 2001;48(4):787-797.
35. Jolesz FA. Future perspectives for intraoperative MRI. Neurosurg Clin N Am. 2005;16(1):201-213. (Pubitemid 39550526)
36. Malhotra V, Malik R, Gondal R, Beohar PC, Parkash B. Evaluation of histological appearance of tissues removed by cavitron ultrasonic surgical aspirator (CUSA). Acta Neurochir (Wien). 1986;81(3-4):132-134. (Pubitemid 16007442)
37. Richmond IL, Hawksley CA. Evaluation of the histopathology of brain tumor tissue obtained by ultrasonic aspiration. Neurosurgery. 1983;13(4):415-419. (Pubitemid 13018046)
38. Blackie RA, Gordon A. Histological appearances of intracranial biopsies obtained using the Cavitron ultrasonic surgical aspirator. J Clin Pathol. 1984;37(10):1101-1104. (Pubitemid 14015701)
39. Mountford CE, Doran S, Lean CL, Russell P. Proton MRS can determine the pathology of human cancers with a high level of accuracy. Chem Rev. 2004; 104(8):3677-3704.
40. Somorjai RL, Dolenko B, Nikulin AK, et al. Classification of 1H MR spectra of human brain neoplasms: the influence of preprocessing and computerized consensus diagnosis on classification accuracy. J Magn Reson Imaging. 1996; 6(3):437-444. (Pubitemid 126707477)
41. Cheng LL, Chang IW, Louis DN, Gonzalez RG. Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens. Cancer Res. 1998;58(9):1825-1832. (Pubitemid 28217454)
42. Tzika AA, Cheng LL, Goumnerova L, et al. Biochemical characterization of pediatric brain tumors by using in vivo and ex vivo magnetic resonance spectroscopy. J Neurosurg. 2002;96(6):1023-1031. (Pubitemid 34579018)
43. Chen H, Pan Z, Talaty N, Raftery D, Cooks RG. Combining desorption electrospray ionization mass spectrometry and nuclear magnetic resonance for differential metabolomics without sample preparation. Rapid Commun Mass Spectrom. 2006;20(10):1577-1584.